2025 annual financial data

Sarepta Therapeutics 2025 Financial results

Direct answer

Revenue was 2,198,237,000 USD.

Operating income was -657,772,000 USD and net income was -713,410,000 USD.
Operating cash flow was -205,479,000 USD.

Get free Sarepta Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
2,198,237,000 USD
Operating income
-657,772,000 USD
Net income
-713,410,000 USD
Operating cash flow
-205,479,000 USD